Physician profile
John W Davis
NPI 1740268978
$15,686.81
in general payments reported to CMS, 2019-2025
18 companies · $204 in 2025
The $204 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,972 · 2020: $4,365 · 2021: $1,768 · 2022: $2,130 · 2023: $200 · 2024: $48.68 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,852.18 | 2019-2023 | Da Vinci Surgical System |
| Conmed Corporation | $352.93 | 2019-2022 | |
| Janssen Biotech, INC. | $185.85 | 2019-2023 | Erleada, Akeega |
| Medtronic, INC. | $174.74 | 2022 | |
| Medtronic Vascular, INC. | $155.92 | 2019 | |
| Ambu INC. | $145.13 | 2022 | |
| Astellas Pharma US INC | $145.03 | 2019-2021 | |
| Pfizer INC. | $113.22 | 2019 | |
| Edap Technomed INC | $99.13 | 2025 | |
| Blue Earth Diagnostics | $92.79 | 2022 | |
| Reflow Medical INC | $82.96 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.92 | 2021 | |
| Progenics Pharmaceuticals, INC. | $73.17 | 2023 | Pylarify |
| Abbott Laboratories | $40.40 | 2021-2022 | |
| Smith+Nephew, INC. | $40.12 | 2023-2024 | Renasys Go V2 Home |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $28.67 | 2024 | Provenge |
| Exelixis INC. | $21.65 | 2025 | Cabometyx |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.